Condition category
Date applied
Date assigned
Last edited
Retrospectively registered
Overall trial status
Recruitment status
No longer recruiting

Plain English Summary

Background and study aims:
Did you know that when people put on excess weight there is an increased danger of unseen liver injury? Fatty liver is up to five times more likely to occur in obese people than those who are a healthy weight.
Fatty liver disease can exist without any symptoms, but it can also progress to serious liver damage. It has a range of disease states from non-threatening fat build-up (steatosis), to inflammatory steatohepatitis and fibrosis (cirrhosis). We know weight loss helps to reduce fatty liver, so disease progression can be reversed at this stage. However, once the disease reaches the fibrosis stage the liver damage is irreversible.

Progression of the disease is thought to be affected by the body’s:
• Resistance to its own insulin
• Coping strategies for excess fat
• Automatic immune defences causing inflammation
These interactions are complex and we are not exactly sure what happens.
We are investigating these interactions, to see what happens when an obese person follows a short-term very strict diet.

Who can participate?
Patients accepted for weight-loss surgery at Derby Hospitals NHS Foundation Trust.

What does the study involve?
• Participants will follow a two-week diet of around 800 kcal/day – either the standard hospital pre-operative diet or a meal replacement plan
• Before the diet - blood tests will be taken, as well as body weight
• During the diet - a food and drink diary will be completed
• After the diet (at the time of the weight-loss surgery) - body weight will be measured, a further blood sample will be taken and biopsies of liver and fat

What are the possible benefits and risks of participating?
Overall, the study should help to identify the effects of the short-term diet on the liver, and wider effects on the body. It should also identify which type of diet is of most benefit to patients undergoing weight-loss surgery.

As the participants follow the standard care pathway there are minimal additional risks. However, taking biopsies is an extra procedure and the surgeon will minimise any discomfort and manage any risks involved in this process.
Where is the study run from?
From the University of Nottingham with the co-operation of the regional Bariatric Surgical Service at Derby Hospitals NHS Foundation Trust.

When is the study starting and how long is it expected to run for?
Study recruitment started in May 2012 and will continue until June 2014, or until we have reached the target number of 100 participants, if sooner.

Who is funding the study?
Schools of Biomedical Sciences and Graduate Entry Medicine and Health, University of Nottingham.
Biotechnology and Biological Sciences Research Council (BBSRC).

Who is the main contact?
Prof Ian Macdonald

Trial website

Contact information



Primary contact

Prof Ian Macdonald


Contact details

Professor of Metabolic Physiology
School of Biomedical Sciences
University of Nottingham Medical School
Queen's Medical Centre
United Kingdom

Additional identifiers

EudraCT number number

Protocol/serial number


Study information

Scientific title

Effects of short-term energy restriction on liver lipid content, metabolism and inflammatory status in severely obese adults



Study hypothesis

A two week period of energy restriction will effect a reduction in liver lipid content, gene expression and plasma inflammatory markers, in severely obese individuals, relative to the level of energy restriction achieved.

Please note that as of 15/03/2013, the anticipated end date for this trial was updated from 31/12/2013 to 30/06/2014

Ethics approval

West Midlands - Coventry and Warwickshire, Health Research Authority, 25 January 2012, ref: 12/WM/0017

Study design

Randomised interventional trial

Primary study design


Secondary study design

Randomised controlled trial

Trial setting


Trial type


Patient information sheet

Not available in web format, please use the contact details below to request a patient information sheet


Hepatology, Surgery


Participants will be assigned randomly, to one of two intervention groups to undertake an energy restrictive diet for two weeks pre-operatively:
1. The Derby Hospitals standard pre-bariatric surgical diet
2. Meal replacement diet using nutritional supplements
Both diets will offer approximately 800kcal/d.

Intervention type



Not Applicable

Drug names

Primary outcome measures

Fatty Liver Assessment

Secondary outcome measures

1. Body Weight Change
2. Diet Compliance
Both measured post intervention

Overall trial start date


Overall trial end date


Reason abandoned


Participant inclusion criteria

1. Patients accepted for weight loss surgery at Derby Hospitals NHS Foundation Trust
2. Male and female participants
3. Lower age limit = 18 years, no upper age limit

Participant type


Age group




Target number of participants

UK Sample Size: 100

Participant exclusion criteria

1. Secondary NAFLD
2. Diabetes mellitus treated by insulin, GLP1 or pioglitazone
3. Excess alcohol intake (exceeding national recommendations)
4. Patients receiving anti-inflammatory medication
5. Pregnancy and lactation
6. Any other condition judged by the investigative team to be clinically significant
Exclusions recommended by LighterLife (meal replacement plan):
7.1. Some cardiac conditions (including heart failure, arrhythmias, valve disease, requiring treatment)
7.2. Some cerebrovascular conditions. (Patients who have suffered cerebrovascular disease may participate if the following conditions are met; more than six months has passed and the patient’s condition is stable)
7.3. Schizophrenia, delusional and bipolar disorder, psychosis
7.4. Epilepsy or history of seizure
7.5. Kidney or liver disease (severe)
7.6. Total lactose intolerance
7.7. Type 1 diabetes
7.8. Anorexia or bulimia or other eating disorder undergoing or awaiting treatment.
7.9. Porphyria
7.10. Taking prescribed anticoagulants, digoxin, lithium or monoamine oxidase inhibitors (MAOIs)
7.11. Unstable angina
7.12. Major depressive disorder

Recruitment start date


Recruitment end date



Countries of recruitment

United Kingdom

Trial participating centre

Professor of Metabolic Physiology
United Kingdom

Sponsor information


University of Nottingham (UK)

Sponsor details

Research Innovation Services
Kings Meadow Campus
Lenton Lane
United Kingdom
+44 (0)115 951 5151

Sponsor type




Funder type

Research council

Funder name

Biotechnology and Biological Sciences Research Council (UK)

Alternative name(s)


Funding Body Type

private sector organisation

Funding Body Subtype

other non-profit


United Kingdom

Results and Publications

Publication and dissemination plan

Not provided at time of registration

Intention to publish date

Participant level data

Not provided at time of registration

Results - basic reporting

Publication summary

Publication citations

Additional files

Editorial Notes